How Emerson’s OPSWAT Cybersecurity Tie-Up Could Reframe Its Automation Story for EMR Investors

إمرسون إلكتريك

Emerson Electric Co.

EMR

0.00

  • In April 2026, OPSWAT, a global critical infrastructure cybersecurity provider, and Emerson announced a global reseller agreement to integrate OPSWAT’s OT patch management technology into Emerson’s Ovation Automation Platform for power and water customers worldwide.
  • This agreement deepens Emerson’s focus on specialized cybersecurity for critical infrastructure, responding to rising cyber threats and tightening regulations across energy and water sectors.
  • Next, we’ll examine how embedding OPSWAT’s OT patch management into Ovation could influence Emerson’s automation-focused investment narrative.

We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Emerson Electric Investment Narrative Recap

To own Emerson today, you generally have to believe in its shift toward higher value automation and software across critical infrastructure, while accepting exposure to cyclical capital spending and legacy energy markets. The OPSWAT reseller agreement reinforces Emerson’s cybersecurity positioning in power and water but does not fundamentally change the key near term catalyst, which remains execution on automation and software growth, or the biggest risk, that weaker end markets and FX pressures could still constrain margins.

Among recent developments, Emerson’s February 2026 guidance for FY2026 net sales growth of about 5.5% and EPS of US$4.78 to US$4.93 is most relevant here. That outlook anchors the current automation focused narrative and frames how investors might judge whether cybersecurity partnerships like OPSWAT help support revenue quality and profitability, or whether lingering cyclicality in energy, chemicals, and industrial projects keeps results closer to mid single digit growth rather than something stronger.

Yet behind that story, investors should also recognize the risk that rising digital native competition in industrial software could...

Emerson Electric's narrative projects $21.3 billion revenue and $3.3 billion earnings by 2028.

Uncover how Emerson Electric's forecasts yield a $164.51 fair value, a 14% upside to its current price.

Exploring Other Perspectives

EMR 1-Year Stock Price Chart
EMR 1-Year Stock Price Chart

Some of the most optimistic analysts once pictured Emerson reaching about US$22.5 billion in revenue and US$3.9 billion in earnings by 2029, so this OPSWAT deal could either support that stronger software centric view or highlight how far reality might differ from those expectations.

Explore 4 other fair value estimates on Emerson Electric - why the stock might be worth as much as 42% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Emerson Electric research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Emerson Electric research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Emerson Electric's overall financial health at a glance.

Seeking Other Investments?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

  • The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 19 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
  • AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Uncover the next big thing with 28 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.